Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you sir...
MADLONG2029
That's just not true!!! When were the R/S's?
Looks like your a dumper...
Hold tight everyone, 3 Net Zero plants in the works!!!
MADLONG2029
Lots of regular people spending their stimulus checks on the next EV stock to move up...
IDEX is getting more eyes on it!
MADLONG2029
Greenrose Acquisition Corp. to Acquire Four Cannabis Companies, Creating a Vertically Integrated and Cash Flow Positive Platform Positioned for Significant Growth
- Transaction to Publicly List a Platform of Cannabis Operators Across Limited License Medical Markets, Newly Approved Recreational Markets and Established, but Highly Fragmented Recreational Markets Where Consolidation Opportunities Exist -
- Total Initial Transaction Value of $210 Million, Maximum Earnout of $110 Million -
- Platform to Have Operations in Seven States, Including Nine Dispensaries and Over 300,000 ft² of Cultivation Producing Approximately 120,000 lbs. of Flower per Year -
- Pro Forma 2021 Revenue and Adjusted EBITDA Guidance of $158 Million and $56 Million, Respectively -
- Greenrose Intends to Raise $150 Million in a Private Placement Consisting of a Mixture of Common Stock and Debt -
AMITYVILLE, N.Y., March 15, 2021 (GLOBE NEWSWIRE) — Greenrose Acquisition Corp. (NASDAQ: GNRSU, GNRS, GNRSW) (Greenrose), a special purpose acquisition company targeting companies in the cannabis industry, has entered into definitive agreements to acquire four cannabis companies (The Platform). The companies are Shango Holdings Inc. (Shango), Futureworks LLC (d/b/a The Health Center), Theraplant, LLC, and True Harvest, LLC.
Prior to closing the transaction, Greenrose will be renamed The Greenrose Holding Company Inc. and is expected to transition its listing from the Nasdaq Capital Market to the OTCQX® Best Market. Additionally, Greenrose intends to list on the NEO exchange after the close of the transaction.
Platform Overview by State
STATE
FOOTPRINT AND HIGHLIGHTS
Arizona
One 74,000 ft² cultivation facility and one processing facility
California
One dispensary, one distribution business
Colorado
Three dispensaries, three cultivation facilities with 58,500 ft² of total cultivation capacity and one processing facility
Connecticut
One 68,000 ft2 combined cultivation, processing, manufacturing and packaging facility under expansion to add another 30,000 ft2; one of four exclusive growers statewide
Michigan
Three dispensaries, one 25,000 ft² cultivation facility and two processing facilities
Nevada
One dispensary, one 20,000 ft² cultivation facility with room to expand to 50,000 ft² and one processing facility
Oregon
One dispensary and an additional dispensary license, two cultivation facilities totaling 10,000 ft² of indoor capacity and 30,000 ft2 of outdoor capacity
Greenrose Investment Highlights
Establishes a Footprint in High Growth Limited License Markets. Through these acquisitions, Greenrose will establish itself in highly profitable, high growth limited license markets such as Arizona, Nevada and the medical market of Connecticut.
Vertically Integrated Operations in Established Recreational Markets. In the established markets of Colorado, Oregon and California, Greenrose will pursue a high risk adjusted return business strategy of consolidating a group of highly fragmented, profitable markets.
Well Capitalized and Cash Flow Positive. Upon closing, the transaction will be immediately Adjusted EBITDA and cash flow positive with ample liquidity to execute Greenrose’s strategic growth objectives.
Rapid Growth Profile. The Platform’s estimated pro forma revenue and Adjusted EBITDA1 in 2020 were $83 million and $32 million, respectively, and are projected to grow to $158 million and $56 million in 2021 and $230 million and $90 million in 2022. This represents a 66% and 68% compounded annual growth rate on pro forma revenue and Adjusted EBITDA, respectively.
Compelling M&A Pipeline. The cannabis market is enjoying strong growth, but attractively priced assets remain available due to capital constraints and companies with non-core assets. Greenrose intends to identify additional complementary companies and select premier retail assets. Through these and other opportunities, Greenrose seeks to both expand further within the states in which the Platform companies currently operate and enter new states.
Comprehensive Management Team. Greenrose will complement the strong team of cultivation, product development and retail managers within the Platform with its own executives, who possess significant corporate-level operational, financial, legal and public company experience.
“The companies we are bringing to market fully align with Greenrose’s core objectives,” said Mickey Harley, CEO and Director of Greenrose. “We are targeting strategic assets in several key states that present opportunities for further consolidation as we seek to deepen our presence, particularly in the West. Additionally, we are entering high growth, limited license markets and newly recreational markets. The Platform provides significant revenue, Adjusted EBITDA and cash flow right out of the gate, which we expect will help us drive our growth strategy.
“Across the Platform, we are targeting acquisitions with the highest quality retail alignment and superior cultivation capabilities, selling the most reputable products in their respective markets at premium prices. On a state-by-state level, we plan to build upon high growth, limited license markets like Nevada, as well as newly recreational and limited license markets like Arizona and Michigan. In emerging medical markets with recreational potential like Connecticut, where our company is generating strong cash flow, we are excited about this growth potential as the market evolves. In established but highly fragmented markets like California, Colorado and Oregon, the goal will be to take advantage of the consolidation opportunities those markets offer, recognizing the favorable risk-reward dynamics of such markets vis-à-vis the newer, limited license markets. We also anticipate evaluating select distressed and undervalued assets.”
Paul Otto Wimer, Greenrose President, commented: “Our collective executive management team has extensive M&A experience and has multi-decade experience in business leadership, operational management and corporate finance. We expect the potential pipeline of longer-term opportunities to expand now that recreational legalization has become more widespread following the 2020 election. As we develop and expand our Platform, we plan to leverage the experience of our combined management team and our scale to accelerate growth.”
Transaction Terms & Financing
Under the terms of the agreement, Greenrose will acquire the Platform for approximately $210 million, consisting of approximately $170 million in cash, $15 million in stock and $25 million in debt, representing an attractive 2021 revenue and Adjusted EBITDA multiple of 1.3x and 3.8x, respectively. In addition, a maximum of $110 million in earnouts could be paid out through 2024, consisting of $75 million in stock and $35 million in debt.
Greenrose intends to commence an offering (the “Offering”) of $150 million in equity and debt securities in a private offering, and to use the net proceeds of such offering for the acquisition of the Platform and general corporate purposes. The interest rate and maturity of any debt securities and the terms of any equity offered will be determined at the time of sale. The Offering will be made only to persons reasonably believed to be accredited or otherwise qualified investors under the Securities Act of 1933, as amended (the “Securities Act”). Any securities sold by Greenrose in the Offering are not expected to be registered under the Securities Act and may not be resold absent registration or unless an exemption from such registration is available. This disclosure is made pursuant to Rule 135c of the Securities Act, and does not constitute an offer to sell securities in the Offering, nor a solicitation for an offer to buy securities in the Offering.
Assuming no redemptions by Greenrose’s public stockholders in connection with the acquisitions, the combined company, post-business combination and post-proposed Offering, will have an estimated $140 million in cash with $75 million in debt. Cash available is anticipated to consist of Greenrose’s approximately $173 million of cash in trust (before any redemptions) and an additional $150 million in gross proceeds from the Offering. In connection with the Offering, Greenrose has received a non-binding term sheet for $80 million, consisting of $40 million debt and $40 million equity.
The net proceeds raised from the transaction will primarily be used to support working capital and fund expansion through additional acquisitions. Giving effect to the anticipated acquisition of the Platform, Greenrose is expected to generate revenue and Adjusted EBITDA of approximately $158 million and $56 million, respectively, in 2021, exclusive of additional M&A activity that Greenrose may undertake.
The board of directors of Greenrose and the governing bodies of each of the Platform companies have unanimously approved the proposed transactions, and they are expected to close in the second or third quarter of 2021, subject to regulatory and stockholder/equity holder approvals, as well as other customary closing conditions.
The tables below provide a synopsis of the assets, offerings and geographic footprint of each of the Platform companies.
Company
Key Geography and Assets
Highlights
Shango
The Health Center
Theraplant
True Harvest
Advisors
Imperial Capital, LLC is acting as capital markets advisor to Greenrose. Tarter Krinsky & Drogin LLP is acting as legal advisor to Greenrose. Gateway Group is serving as communications advisor to Greenrose.
Webinar
Greenrose has made available a video webinar to discuss the proposed transaction. To watch the video, click here and use the password: GNRS2021!
The presentation accompanying the webinar can also be accessed via Greenrose’s website at: greenrosecorp.com.
About Greenrose
Greenrose Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Following the transactions forming the Platform, Greenrose will be a vertically integrated, multistate operator cannabis company. For more information, visit greenrosecorp.com.
About Shango
Shango is an established vertically integrated cannabis brand offering a full range of award-winning products, including flower, extracts and cannabis-infused edibles, in California, Oregon, Michigan and Nevada, with additional cultivation and distribution operations in Arizona and California, respectively. The Shango brand has multiple full-service recreational and medical cannabis dispensaries in Oregon and Nevada, as well as a medical cannabis provisioning center in Michigan. A recognized leader in the cannabis industry, Shango sets the standards for product quality, consistency and business conduct. Shango is committed to cannabis education and is a fierce advocate of the safe and responsible use of cannabis products. For more information, go to www.goshango.com.
About The Health Center
The Health Center is a vertically integrated cannabis company operating in the Colorado market. Boasting upwards of 40 varieties of award-winning strains at any given time, the THC team prides itself on offering the best variety, potency, and effectiveness of any cannabis in the region. In addition to their cultivation business, THC operates as a manufacturer of infused products through “MIPs” operations and three retail stores. For more information, please visit www.thchealth.com.
About Theraplant
Locally owned and operated, Theraplant was Connecticut’s first state-licensed medical marijuana producer and in October 2014 became the first producer to distribute medical cannabis in the Connecticut market. Theraplant designs premium cannabis genetics to offer a wide variety of compositions to meet needs of the state’s medical cannabis cardholders for all approved treatment conditions. Theraplant continually leads the market in making quality medical cannabis affordable to the greatest range of patients. For more information, visit www.theraplant.com.
About True Harvest
True Harvest is a premium craft cannabis producer operating one of the largest indoor cannabis facilities in Arizona. True Harvest is passionate about growing the finest cannabis and preserving the health and well-being of its medical patients, employees and community. The True Harvest team takes personal pride in delivering meticulous plant care and exceptional cannabis experiences, with cultivation operations based in Arizona.
MADLONG2029
I added during the dip!!!
It’s been crazy, however trading stock based on emotions and fear are bad policy!!!
Your data has been very helpful. Thank you for sharing!!!
MADLONG2029
TDAmertrade has not exchanged them yet!
MADLONG2029
I can’t believe the opportunity to buy under $7!!!!
I added!!!
MADLONG2029
I'm seriously looking adding to my High Tides (HITIF) with at least half my of my old LHSIF/ new AYR Wellness shares.
Check in out, see some of you on other boards.
MADLONG2029
Congrats to everyone who wanted the deal, my condolences to those who didn't!
Now we need to decide what to do with our new shares...
MADLONG2029
Cannabis Stock Gainers And Losers From February 23, 2021
Jose Rodrigo Safdiye 2 hrs ago
© Provided by Benzinga
GAINERS: Rhinomed (OTCQB: RHNMF) shares closed up 19.94% at $0.10 GTEC Holdings (OTCQB: GGTTF) shares closed up 18.06% at $0.60 High Tide (OTCQB: HITIF) shares closed up 11.69% at $0.62 Chemesis International (PINK: CADMF) shares closed up 6.38% at $0.74 4Front Ventures (OTCQX: FFNTF) shares closed up $4.49% at $1.86
LOSERS: AusCann Group Holdings (PINK: ACNNF) shares closed down 19.77% at $0.13 Empower Clinics (PINK: EPWCF) shares closed down 19.1% at $1.44 Flower One Hldgs (OTCQX: FLOOF) shares closed down 11.55% at $0.28 Cannabics Pharmaceuticals (OTCQB: CNBX) shares closed down 11.09% at $0.45 22nd Century Group, Inc. Common Stock (AMEX:XXII) shares closed down 11.08% at $3.81 Genetic Technologies (NASDAQ: GENE) shares closed down 10.78% at $4.47 Zenabis Global (PINK: ZBISF) shares closed down 10.64% at $0.11 The Flowr (PINK: FLWPF) shares closed down 9.82% at $0.29 Helix Technologies (OTCQB: HLIX) shares closed down 9.76% at $0.74 ReneSola (NYSE: SOL) shares closed down 9.76% at $14.33 MedMen Enterprises (OTCQX: MMNFF) shares closed down 9.69% at $0.43 Item 9 Labs (OTCQB: INLB) shares closed down 8.86% at $3.19 Corbus Pharmaceuticals (NASDAQ: CRBP) shares closed down 8.33% at $2.53 Primo Nutraceuticals (PINK: BUGVF) shares closed down 8.33% at $2.75 Meridian Bioscience (NASDAQ: VIVO) shares closed down 7.74% at $21.23 MGC Pharmaceuticals (PINK: MGCLF) shares closed down 7.23% at $0.08 Charlottes Web Holdings (NASDAQ: CWBHF) shares closed down 6.75% at $5.25 OrganiGram Holdings (NASDAQ: OGI) shares closed down 6.75% at $3.04 Aphria (NASDAQ: APHA) shares closed down 6.67% at $18.06 C21 Investments (OTCQX: CXXIF) shares closed down 6.36% at $1.62 MariMed (OTCQX: MRMD) shares closed down 6.08% at $0.74 Tilray (NASDAQ: TLRY) shares closed down 5.71% at $24.79 Cronos Group (NASDAQ: CRON) shares closed down 4.79% at $11.13 Canopy Gwth (NASDAQ: CGC) shares closed down 4.59% at $35.31 Village Farms Intl (NASDAQ: VFF) shares closed down 4.51% at $15.66
MADLONG2029
Cannabis Stock Gainers And Losers From February 23, 2021
Jose Rodrigo Safdiye 2 hrs ago
© Provided by Benzinga
GAINERS: Rhinomed (OTCQB: RHNMF) shares closed up 19.94% at $0.10 GTEC Holdings (OTCQB: GGTTF) shares closed up 18.06% at $0.60 High Tide (OTCQB: HITIF) shares closed up 11.69% at $0.62 Chemesis International (PINK: CADMF) shares closed up 6.38% at $0.74 4Front Ventures (OTCQX: FFNTF) shares closed up $4.49% at $1.86
LOSERS: AusCann Group Holdings (PINK: ACNNF) shares closed down 19.77% at $0.13 Empower Clinics (PINK: EPWCF) shares closed down 19.1% at $1.44 Flower One Hldgs (OTCQX: FLOOF) shares closed down 11.55% at $0.28 Cannabics Pharmaceuticals (OTCQB: CNBX) shares closed down 11.09% at $0.45 22nd Century Group, Inc. Common Stock (AMEX:XXII) shares closed down 11.08% at $3.81 Genetic Technologies (NASDAQ: GENE) shares closed down 10.78% at $4.47 Zenabis Global (PINK: ZBISF) shares closed down 10.64% at $0.11 The Flowr (PINK: FLWPF) shares closed down 9.82% at $0.29 Helix Technologies (OTCQB: HLIX) shares closed down 9.76% at $0.74 ReneSola (NYSE: SOL) shares closed down 9.76% at $14.33 MedMen Enterprises (OTCQX: MMNFF) shares closed down 9.69% at $0.43 Item 9 Labs (OTCQB: INLB) shares closed down 8.86% at $3.19 Corbus Pharmaceuticals (NASDAQ: CRBP) shares closed down 8.33% at $2.53 Primo Nutraceuticals (PINK: BUGVF) shares closed down 8.33% at $2.75 Meridian Bioscience (NASDAQ: VIVO) shares closed down 7.74% at $21.23 MGC Pharmaceuticals (PINK: MGCLF) shares closed down 7.23% at $0.08 Charlottes Web Holdings (NASDAQ: CWBHF) shares closed down 6.75% at $5.25 OrganiGram Holdings (NASDAQ: OGI) shares closed down 6.75% at $3.04 Aphria (NASDAQ: APHA) shares closed down 6.67% at $18.06 C21 Investments (OTCQX: CXXIF) shares closed down 6.36% at $1.62 MariMed (OTCQX: MRMD) shares closed down 6.08% at $0.74 Tilray (NASDAQ: TLRY) shares closed down 5.71% at $24.79 Cronos Group (NASDAQ: CRON) shares closed down 4.79% at $11.13 Canopy Gwth (NASDAQ: CGC) shares closed down 4.59% at $35.31 Village Farms Intl (NASDAQ: VFF) shares closed down 4.51% at $15.66
MADLONG2029
Anyone heard from FROZEN????
MADLONG2029
Holding on during the last dip paid off!!!
This is a winner from all my DD, so let’s just hang on as we roller coaster our way up!!!
MADLONG2029
There certainly could be a correction going on here, however I am going to add today afternoon, if we continue to remain low, There is no reason to sell, I am long here!!!
Hang on!
MADLONG2029
Great walk thru of the thought patterns during one of these parabolic moves! Thinking through the options ahead of time or right after the event is an incredible ways of learning!!!
I personally lighted up Wednesday evening, just not near enough or broadly enough!!! I be less ‘drunk’ next time because of this mental walk through!!!
Thank you for your continued contributions here!
MADLONG2029
I am one of the new guys here, however the reason ALLM has risen is the political environment and a shift to Green energy and hence Blue Gas. ALLM is going to be eligible for huge federal grants, funding will be available for the next 4 years.
There has been news, if it’s legitimate is anyones quest. I personally saw ALLM in a article with GEVO which has went from under $2 to $14ish. GEVO is also very volatile, with huge gains and huge declines. However it has stair stepped to around $14
At this point ALLM has the potential to follow GEVO. That means being volatile too! That’s why I invested here,. I flipped my entire stack once already, increasing my holdings by 17%
I hope this helps you see there is a reason ALLM is going up, or at least why I believe it is moving up.
MADLONG2029
I too found the dip an opportunity to add! Missed the last dip because I had no funds, was ready this time!
I pick B
MADLONG2029
Thanks, I may be alone here...
Glad to see this move up and find a new floor in the .70’s
Also happy to see others here, I knew it would happen!
MADLONG2029
Good morning Scum and all HCANF holders
Great to hear your up over 100%!!!
I see the name change has happened.
Doing very well myself in all the green stocks, several are up over 300%. Bio Fuel has been my biggest money makers!!!
MADLONG2029
Could be another step up!!!
MADLONG2029
Good morning everyone.
I'm a shareholder of PLUUF. If this goes through you're getting a quality company with incredible assets! IMO its our uranium holdings that really made this deal happen.
Drop by the PLUUF board and check out the PLUUF website.
MADLONG2029
Thanks, and DD has begun!
MADLONG2029
Oh, it’s so good to see someone else here!!!!!
It has been lonely, but I knew some day, someone would come by...
Yes this is a great investment, look it over and do your DD!
MADLONG2029
It jumped up to $13.79 in after hours trading!!!
MADLONG2029
Time for some eyes here.
Up 21% today!!!
A double win here. Lithium and uranium!!!
MADLONG2029
I'm up 1256% today!!!
My green investments, cannabis, EV companies, BIO Fuel can't hold a stick compared to CBMJ.
I wish another cannabis would go God too!!!!
MADLONG2029
How many cannabis investors are left here???
Shout out, we're in at such a low level.
MADLONG2029
I'm looking for a pull back!
It's natural and healthy after Fridays run up.
MADLONG2029
Closed at $11.72...
MADLONG2029
I agree 100%, their process seems sound and proprietary, finances seem shaky, however there is going to be tons of free money for sugar based Blue fuels!!!
GEVO should be getting out some news and this will jump up another leg, maybe to $15- $17!!!
I love the green movement!!!
MADLONG2029
Oh yea, I'm still over 250% green!!!
Averaged up with buys during some dips.
I came late and still up big!!!!
MADLONG2029
IDEX and ALLM picked up the slack!!!
Great day when GEVO's red and I'm still green!!!
Still has so much more to grow, days like today are just part of the health run up!!!
MADLONG22029
Moving in the right direction!!!
Hope the worm has turn for all the longs here!
Frozen and I may have brought some luck, we're sitting on rocket ships with a couple of other holds...
Hi there other new guy, FROZEN, let's make some money here too!
MADLONG2029
Anyone alive here any more?
MADLONG2029
GEVO would benefit from the funds if this passes!!!
MADLONG2029
BROWNLEY INTRODUCES ‘SUSTAINABLE AVIATION FUEL ACT’ TO REDUCE CARBON EMISSIONS
February 3, 2021 | Press Releases
Washington, DC – Today, Congresswoman Julia Brownley (D-CA) introduced the Sustainable Aviation Fuel Act, legislation to incentivize the production of sustainable aviation fuel (SAF) and help the aviation sector reduce carbon emissions.
“We are facing an existential threat to the future of our planet. In order to face this threat head on, we must be creative, be innovative, and act quickly. We must do so wherever we can make a difference,” said Congresswoman Julia Brownley. “Sustainable aviation fuel is a key component to decarbonize the aviation industry, but we need to scale up production and distribution if we are to achieve our climate goals.”
“Airlines must put climate change at the center of their recovery, and sustainable aviation fuels can play an important role in reducing the industry’s environmental impact. Rep Brownley’s Sustainable Aviation Fuel Act will drive innovation and demand for high-quality sustainable aviation fuels that could dramatically lower airline emissions,” said Kelley Kizzier, Vice President of Global Climate, Environmental Defense Fund.
“Aviation emissions are projected to triple by 2050, but there is a route for the aviation industry to support a climate-safe and more environmentally sound future for the planet. Powering planes with sustainable aviation fuels is an indispensable step along this journey, and Congress can help realize it by passing Rep. Brownley’s Sustainable Aviation Fuel Act,” said Brad Schallert, Director of Carbon Market Governance and Aviation, World Wildlife Fund.
“Strong standards are needed to rapidly decarbonize transportation, and a Low Carbon Aviation Fuel Standard is a smart strategy to drive innovation in a hard-to-decarbonize part of the transportation sector. We appreciate Rep. Brownley’s leadership and look forward to working together to build a cleaner transportation future,” said Jeremy Martin, Senior Scientist and Director of Fuels Policy, Union of Concerned Scientists.
The Sustainable Aviation Fuel Act includes a number of different policy options that Congress should consider that address SAF production and distribution challenges from different directions. The bill would create a new blender’s tax credit for SAF, linked to carbon reductions, as well as an Investment Tax Credit to help finance new SAF facilities and infrastructure. It would authorize $1 billion in federal funding for U.S. projects that produce, transport, blend, or store SAF. It would authorize $175 million in research funding to push the limits of existing SAF technology to try to lower SAF carbon emissions even more. It would require the EPA to establish an aviation-only Low Carbon Fuel Standard (LCFS) similar to California’s successful transportation-wide LCFS.
Background
The aviation sector accounts for 2.6 percent of total U.S. greenhouse gas emissions and 9 percent of emissions by the U.S. transportation sector. While decarbonization of surface transportation modes is focused heavily on electrification and fuel cell technology, the development of such technology in the aviation industry is just beginning. So, in the near term, the aviation sector will continue to be reliant on liquid fuels.
SAF is a drop-in fuel, which is an interchangeable substitute for fossil jet fuel up to a certain blending percentage. It therefore functions the same as fossil jet fuel while also meeting certain sustainability criteria. For the purposes of the Sustainable Aviation Fuel Act, only SAF that achieves at least a 50% reduction in greenhouse gases compared to fossil jet fuel on a lifecycle basis will qualify for the various incentives in the bill. Multiple types of SAF have been certified by ASTM International as safe for use in airplanes up to certain maximum blending limits.
Since 2011, more than 200,000 flights have used SAF. However, while SAF is beginning to be produced both in the U.S. and internationally, it is not being done fast enough to achieve our long-term climate change goals. Additionally, the same feedstocks that are used to produce SAF are also used to produce renewable diesel (RD), which is primarily used in ground transportation and cannot be used for aviation. RD is marginally cheaper to produce than SAF and enjoys policy incentives that SAF does not, which means that producers are incentivized to make RD rather than SAF. Congress must fix this policy disparity. Failure to do so will have long-term consequences for the climate, because ground transportation has better options to decarbonize than aviation does, namely through electrification and fuel-cells, and waiting to build out sufficient SAF production infrastructure could hinder the aviation sector’s ability to decarbonize quickly.
https://juliabrownley.house.gov/brownley-introduces-sustainable-aviation-fuel-act-to-reduce-carbon-emissions/
MADLONG2029
MMM, I voted YES with recommendations.
So not sure what your talking about saying there is no way to vote yes.
Held LHSIF since January 2019
MADLONG2029
I said I was new, and challenged about the stupid word ‘hurdles’.
Seems like a lot of defensive people here!
Just here to make money, please hold the drama!!!
MADLONG2029
Have you not read this board???
Bankruptcy is a BIG hurdle!!!!
Do I need to re-post it now???
MADLONG2029
Looks like some hurdles have certainly been jumped.
I got in yesterday at .58, so I'm new here on the ALLM board.
Looking to make some money!!!
MADLONG2029